JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Smallcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
JB Chemicals & Pharmaceuticals announced the results of its postal ballot on five ordinary resolutions, all of which were approved by shareholders with overwhelming majority (over 99% in favor). The key resolution was the appointment of Mr. Aman Mehta (DIN: 08174906) as Managing Director, which received 99.85% support. Additionally, Mr. Aman Mehta was appointed as a Director (99.26%), and three others — Mr. Amal Kelshikar, Mr. Hasmukh Patel, and Mr. Sudhir Menon — were appointed as Non-Executive Non-Independent Directors, each receiving over 99.8% approval. The e-voting was held from February 22 to March 23, 2026, with around 13 crore shares (80.99% of paid-up capital) participating. Promoters voted 100% in favor of all resolutions. The Scrutinizer confirmed the results were fair and transparent.
Shareholders have given a strong mandate to the new leadership team, especially Mr. Aman Mehta as the new Managing Director, signaling confidence in the company's direction. The near-unanimous approval suggests minimal investor dissent on the board changes.